2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation - Steffel, Jan; Collins, Ronan; Antz, Matthias; Cornu, Pieter; Desteghe, Lien; Haeusler, Karl Georg; Oldgren, Jonas; Reinecke, Holger; Roldan-Schilling, Vanessa; Rowell, Nigel; Sinnaeve, Peter; Vanassche, Thomas; et al. (Europace (London, England), 2021)
Keywords: Administration, Oral; Anticoagulants - adverse effects; apixaban; Atrial Fibrillation - complications; Atrial Fibrillation - diagnosis; Atrial Fibrillation - drug therapy; dabigatran; Dabigatran - therapeutic use; DOACs; edoxaban; EHRA Practical Guide; Humans; NOACs; Official Statement; Pyridones - therapeutic use; rivaroxaban; Rivaroxaban - therapeutic use; Stroke - diagnosis; Stroke - etiology; Stroke - prevention & control; NOACs; dabigatran; rivaroxaban; DOACs; apixaban; edoxaban